Divergent Evolution and Local Establishment of Multidrug-Resistant Shigella sonnei in China
Kangkang Liu , Jian Wang , Chaojie Yang , Yehong Yang , Xin Ge , Hongbo Liu , Xinying Du , Ying Xiang , Kaiyuan Min , Qi Wang , Hui Wang , Chao Wang , Huiqun Jia , Mingjuan Yang , Xiaoying Li , Ligui Wang , Yong Sun , Muti Mahe , Jiayong Zhao , Shijun Li , Deshan Yu , Stephen Baker , Jiangfeng Liu , Xuebin Xu , Hongbin Song , Shaofu Qiu , Juntao Yang
MedComm ›› 2026, Vol. 7 ›› Issue (1) : e70569
This study explored the microevolution of Shigella sonnei in China, focusing on 281 isolates exhibiting coresistance to ceftriaxone and azithromycin (cefR aziR) and 99 ONPG-negative isolates. Phylogenetic analysis revealed that waterborne outbreak strains, characterized by multidrug resistance (MDR) and cefR aziR, clustered within the predominant domestic lineage I. In contrast, sporadic MDR strains harboring a wider array of antimicrobial resistance (AMR) genes were primarily associated with lineage II. The cefR aziR phenotype in lineage I was mediated by an IncB/O/K/Z plasmid carrying blaCTX-M-14, mphA, aac(3)-IId, dfrA17, aadA5, and sul1 genes. Lineage II strains acquired cefR aziR through a distinct IncFII plasmid possessing blaCTX-M-15, ermB, and mphA genes, and additionally carried a separate IncB/O/K/Z plasmid backbone with blaTEM-1, dfrA12, sul2, strA, strB, tet(A), and aac(3)-IId genes. Conversion to the ONPG-negative phenotype was linked to a deletion spanning approximately 10 kbp, which included two insertion sequences (IS1 and IS600), the mhpBAR operon, and the lacIZY operon. Genomic comparisons identified 66 SNPs and 9 accessory genes correlated with lineage II, and 23 SNPs with 9 accessory genes associated with ONPG-negative variants. Ongoing surveillance of S. sonnei epidemic clones is essential to elucidate their microevolution, track transmission, and assess public health implications.
microevolution / multidrug resistance / ONPG-negative variants / Shigella sonnei / whole-genome sequencing
| [1] |
|
| [2] |
|
| [3] |
World Health Organization Antimicrobial Resistance: Global Report on Surveillance 2014. WHO, 2014. |
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
Clinical and Laboratory Standards Institute 2021. Performance Standards for Antimicrobial Susceptibility Testing: 31st Edition. CLSI supplement M100. Wayne, PA. |
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
|
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
2026 The Author(s). MedComm published by Sichuan International Medical Exchange & Promotion Association (SCIMEA) and John Wiley & Sons Australia, Ltd.
/
| 〈 |
|
〉 |